Title: Neuroprotective Properties of the Uncompetitive NMDA Receptor Antagonist Remacemide Hydrochloride
Abstract: Annals of the New York Academy of SciencesVolume 765, Issue 1 p. 236-247 Neuroprotective Properties of the Uncompetitive NMDA Receptor Antagonist Remacemide Hydrochloride GENE C. PALMER, Corresponding Author GENE C. PALMER Biology Department Fisons Pharmaceuticals P.O. Box 1710 Rochester, New York 14603Recipient of communications and requests for reprints.Search for more papers by this authorEDWARD F. CREGAN, EDWARD F. CREGAN Biology Department Fisons Pharmaceuticals P.O. Box 1710 Rochester, New York 14603Search for more papers by this authorALFONSO R. BORRELLI, ALFONSO R. BORRELLI Biology Department Fisons Pharmaceuticals P.O. Box 1710 Rochester, New York 14603Search for more papers by this authorFRANCES WILLETT, FRANCES WILLETT Department of Medical Affairs Fisons plc Pharmaceutical Division Research and Development Laboratories Bakewell Road, Loughborough Leicestershire LE 11 ORH, United KingdomSearch for more papers by this author GENE C. PALMER, Corresponding Author GENE C. PALMER Biology Department Fisons Pharmaceuticals P.O. Box 1710 Rochester, New York 14603Recipient of communications and requests for reprints.Search for more papers by this authorEDWARD F. CREGAN, EDWARD F. CREGAN Biology Department Fisons Pharmaceuticals P.O. Box 1710 Rochester, New York 14603Search for more papers by this authorALFONSO R. BORRELLI, ALFONSO R. BORRELLI Biology Department Fisons Pharmaceuticals P.O. Box 1710 Rochester, New York 14603Search for more papers by this authorFRANCES WILLETT, FRANCES WILLETT Department of Medical Affairs Fisons plc Pharmaceutical Division Research and Development Laboratories Bakewell Road, Loughborough Leicestershire LE 11 ORH, United KingdomSearch for more papers by this author First published: September 1995 https://doi.org/10.1111/j.1749-6632.1995.tb16580.xCitations: 22AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Palmer, G. C., B. Clark & J. B. Hutchison. 1993. Drugs Future 18: 1021–1042. 2 Palmer, G. C., V. Jamieson & T. Jones. Remacemide hydrochioride. In Epilepsy, a Comprehensive Textbook. J. Engel & T. A. Pedley, Eds. Raven Press. New York . In press. 3 Wamil, A. W., H. Cheung, H. Harris, & M. J. McLean. Epilepsy Res. In press. 4 Cramer, C. L., M. L. Stagnitto, M. A. Knowles & G. C. Palmer. 1994. Life Sci. 54: PL271–PL274. 5 Macdonald, R. L. 1989. Epilepsia 30(Suppl. 1): S19–S28. 6 Rogawski, M. A. 1992. Drugs 44: 279–292. 7 Harris, E., M. Stagnitto, G. Garske, E. Cregan, R. Ray, R. Julien, T. Wilson, G. Machulskis, P. Bialobok, J. White & G. Palmer. 1992. Neuroprotection in animals by remacemide, a prodrug for noncompetitive NMDA antagonism with a high therapeutic index. In Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Neuroprotection? J-M Kamenka & E. F. Domino, Eds. 643–653. NPP Books. Ann Arbor , MI . 8 Subramaniam, S., S. D. Donevan & M. A. Rogawski. 1993. Soc. Neurosci. 19: 712. 9 Porter, H. P. & J. T. Greenamyre. 1995. J. Neurochem. 64: 614–623. 10 Olney, J. W. 1989. Drug Dev. Res. 17: 299–319. 11 Porsche-Wiebking, E. 1989. Drug Dev. Res. 17: 367–376. 12 McCulloch, J. 1992. Br. J. Clin. Pharmacol. 34: 106–114. 13 Willets, J., R. L. Balster & J. D. Leander. 1990. TIPS 11: 423–428. 14 Wilmot, C. A. 1989. Drug Dev. Res. 17: 339–365. 15 Pulsinelli, W. A. & A. Buchan. 1990. The NMDA receptor/ion channel: its importance to in vivo ischemic injury to selectively vulnerable neurons. In Pharmacology of Cerebral Ischemia. J. Krieglestein & H. Oberpichler, Eds. 169–175. Wissenschaftliche Verlagsgellschaft. Stuttgart . 16 Buchan, A. & W. A. Pulsinelli. 1990. J. Neurosci. 10: 311–316. 17 Corbett, D., S. Evans, T. C. Wang & R. A. Jones. 1990. Brain Res. 514: 300–304. 18 Chapman, A. G., J. H. Swan, S. Patel, J. L. Graham & B. S. Meldrum. 1990. Cerebroprotective and anticonvulsant action of competitive and non-competitive NMDA antagonists. In Amino Acids, Chemistry, Biology and Medicine. G. Lubec & G. A. Rosenthal, Eds. 219–232. ESCOM Science Publishers. Amsterdam . 19 Swan, J. H. & B. S. Meldrum. 1990. J. Cereb. Blood Flow Metab. 10: 343–351. 20 Lin, B., W. D. Dietrich, M. D. Ginsberg, M. Y-T. Globus & R. Busto. 1993. J. Cereb. Blood Flow Metab. 13: 925–932. 21 Grotta, J. C., C. M. Picone, P. T. Ostrow, R. A. Strong, R. M. Earls, L. P. Lao, H. M. Rhoades & J. R. Dedman. 1990. Ann Neurol. 27: 612–619. 22 Pulsinelli, W., U. Dimagi, M. Jacewicz & A. Buchan. 1992. Antagonists of excitatory amino acid neurotransmitters: a comparison of their effects on global versus focal ischemia. In Alfred Benzon Symposium. A. Schousboe, N. H. Biemer & H. Kofod, Eds. 225–238. Munksgaard. Copenhagen . 23 Ordy, J. M., B. Volpe, R. Murray, G. Thomas, P. Bialobok, T. M. Wegenack & W. Dunlap. 1992. Pharmacological effects of remacemide and MK-801 on memory and hippocampal CA1 damage in the rat four-vessel occlusion (4-VO) model of global ischemia. In The Role of Neurotransmitters in Brain Injury. M. Globus & W. D. Dietrich, Eds. 83–92. Plenum Press. New York . 24 Volpe, B. T. & C. K. Petito. 1985. Neurology 35: 1793–1797. 25 Michenfelder, J. D., W. L. Lanier, B. W. Scheithauer, W. J. Perkins, G. T. Shearman & J. H. Milde. 1989. Brain Res. 481: 228–234. 26 Buchan, A. M., D. Xue & A. Slivka. A new model of temporary focal neocortical ischemia in the rat. 1992. Stroke 23: 273–279. 27 Xue, D., Z. G. Huang & A. M. Buchan. 1993. Can. J. Neurol. 20(Suppl. 2): S75. 28 Grotta, J. C. 1991. Clin. Neuropharmacol. 14: 373–390. 29 Zuccarello, M. & D. K. Anderson. 1989. Stroke 20: 367–371. 30 Koenig, H., J. J. Trout, A. D. Gladstone & C. Y. Lu. 1992. Brain Res. 588: 297–303. 31 Zuccarello, M., J. T. Marsch, G. Schmitt, J. Woodward & D. K. Anderson. 1989. J. Neurosurg. 71: 98–104. 32 Greenamyre, J. T. & C. F. O'brien. 1991. Arch. Neurol. 48: 977–981. 33 Greenamyre, J. T., R. V. Eller, A. Zhang, A. Olvadia, R. Kurlan & D. M. Gash. 1994. Ann. Neurol. 35: 655–661. 34 Muir, K. W. & Lees, K. R. 1995. Initial experience with remacemide hydrochloride in patients with acute ischaemic stroke. Ann. N.Y. Acad. Sci. This volume. 35 Harrison, M. J. G., A. Schneidau, R. Ho, P. L. C. Smith, S. Newman & T. Treasure. 1989. Stroke 20: 235–237. 36 Shaw, P. J., D. Bates, N. E. F. Cartlige, J. M. French, D. Heavside, D. G. Julian & D. A. Shaw. 1987. Q. J. Med. 239: 259–268. 37 Savageau, J. A., B. Stanton, C. D. Jenkins & R. W. M. Fraser. 1982. J. Thorac. Cardiovasc. Surg. 84: 595–600. 38 Pugsley, W., L. Klinger, C. Paschalis, S. Newman, M. Harrison & T. Treasure. 1990. Vasc. Surg. 24: 34–43. Citing Literature Volume765, Issue1Neuroprotective Agents: Clinical and Experimental AspectsSeptember 1995Pages 236-247 ReferencesRelatedInformation
Publication Year: 1995
Publication Date: 1995-09-01
Language: en
Type: review
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 30
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot